Patents by Inventor Khalil Bdeir

Khalil Bdeir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of angiogenesis by neutrophil alpha-defensins
    Patent number: 7998932
    Abstract: The present invention relates to the inhibition of angiogenesis by neutrophil alpha-defensins. Further, the present invention relates to methods involving the inhibition of endothelial cell adhesion to the extracellular matrix, endothelial cell apoptosis, and endothelial cell angiogenesis mediated by alpha-defensins.
    Type: Grant
    Filed: October 8, 2008
    Date of Patent: August 16, 2011
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Douglas Cines, Khalil Bdeir, Klaus T. Preissner, Triantafylios Chavakis
  • Inhibition of adhesion and migration of an endothelial cell to fibronectin by neutrophil alpha-defensins
    Patent number: 7576060
    Abstract: The present invention relates to the inhibition of angiogenesis by neutrophil alpha-defensins. Further, the present invention relates to methods involving the inhibition of endothelial cell adhesion to the extracellular matrix, endothelial cell apoptosis, and endothelial cell angiogenesis.mediated by alpha-defensins.
    Type: Grant
    Filed: July 20, 2005
    Date of Patent: August 18, 2009
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Douglas Cines, Khalil Bdeir, Triantafyllos Chavakis, Klaus T. Preissner
  • Inhibition of Angiogenesis by Neutrophil Alpha-Defensins
    Publication number: 20090075893
    Abstract: The present invention relates to the inhibition of angiogenesis by neutrophil alpha-defensins. Further, the present invention relates to methods involving the inhibition of endothelial cell adhesion to the extracellular matrix, endothelial cell apoptosis, and endothelial cell angiogenesis mediated by alpha-defensins.
    Type: Application
    Filed: October 8, 2008
    Publication date: March 19, 2009
    Inventors: Douglas Cines, Khalil Bdeir, Klaus T. Preissner, Triantafylios Chavakis
  • Inhibition of angiogenesis by neutrophil alpha-defensins
    Publication number: 20060074020
    Abstract: The present invention relates to the inhibition of angiogenesis by neutrophil alpha-defensins. Further, the present invention relates to methods involving the inhibition of endothelial cell adhesion to the extracellular matrix, endothelial cell apoptosis, and endothelial cell angiogenesis.mediated by alpha-defensins. b) instructions for the use of said ?-defensin for the purpose of modulating a biological process associated with said endothelial cell.
    Type: Application
    Filed: July 20, 2005
    Publication date: April 6, 2006
    Inventors: Douglas Cines, Khalil Bdeir, Triantafyllos Chavakis, Klaus Preissner